HomeCMRA • OTCMKTS
add
Comera Life Sciences Holdings Inc
Previous close
$0.00010
Market cap
3.07K USD
Avg Volume
562.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 633.10K | 97.95% |
Operating expense | 10.89M | 91.29% |
Net income | -18.00M | -230.24% |
Net profit margin | -2.84K | -66.83% |
Earnings per share | — | — |
EBITDA | -10.38M | -90.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 446.61K | -93.14% |
Total assets | 3.73M | -49.75% |
Total liabilities | 5.46M | 337.71% |
Total equity | -1.73M | — |
Shares outstanding | 22.30M | — |
Price to book | -0.00 | — |
Return on assets | -117.43% | — |
Return on capital | -236.24% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -18.00M | -230.24% |
Cash from operations | -9.77M | -160.03% |
Cash from investing | -28.61K | 79.86% |
Cash from financing | 5.24M | -49.00% |
Net change in cash | -4.56M | -171.44% |
Free cash flow | -4.98M | -172.64% |
About
Founded
2014
Headquarters
Employees
13
